Skip to main content
Lilie Lin, MD, Radiation Oncology, Houston, TX

Lilie L Lin MD


Professor, Radiation Oncology, MD Anderson Cancer Center

Join to view full profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

  • Fax+1 215-349-5923

Dr. Lin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 2002 - 2006
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2001 - 2002
  • WashU Medicine
    WashU MedicineClass of 2001

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 2017 - 2027
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • PA State Medical License
    PA State Medical License 2006 - 2018
  • NJ State Medical License
    NJ State Medical License 2006 - 2017
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • MD Anderson Research Highlights Special Edition: ASTRO 2024
    MD Anderson Research Highlights Special Edition: ASTRO 2024September 27th, 2024
  • It Takes a Team to Get Through Primary Peritoneal Cancer
    It Takes a Team to Get Through Primary Peritoneal CancerApril 23rd, 2019
  • What’s Next in Cancer Research?
    What’s Next in Cancer Research?September 8th, 2026

Grant Support

  • The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in ZambiaUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
  • Breast Cancer PARP PET Imaging AIP to Support FDA Approval & CommercializationUNIVERSITY OF PENNSYLVANIA2021–2026
  • A novel PARP inhibitor PET tracer for breast cancerUNIVERSITY OF TX MD ANDERSON CAN CTR2021–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: